AS
Adrian Senderowicz
Director

Adrian Senderowicz insider trades: Puma Biotechnology (PBYI) stock sales

Director, Puma Biotechnology Last trade Jun 12, 2026 33 Form 4 filings
$194K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2019
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Adrian reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 12, 2026PBYI↓ Sell$194K
Jun 13, 2025PBYI↓ Sell$92K
Jun 13, 2024PBYI↓ Sell$90K
Jun 13, 2023PBYI↓ Sell$93K
Jun 16, 2022PBYI↓ Sell10b5-1$73K
Jun 11, 2021PBYI↓ Sell$458K
Jun 11, 2020PBYI↓ Sell$99K
May 12, 2020CNST↓ Sell$469K
Nov 6, 2019CNST↓ Sell$766K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PBYI insiders

Open-market trades in the last 12 months

About Adrian Senderowicz's insider trades

Adrian Senderowicz is a director at Puma Biotechnology (PBYI). Since Nov 6, 2019, Adrian has reported no open-market purchases and 9 sales worth $2.3M on SEC Form 4. In the last 12 months: 1 sale ($194K).

1 sale (3% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include grants and awards (25 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PBYI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.